Cargando…
HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease
In Lesch–Nyhan disease (LND), deficiency of the purine salvage enzyme hypoxanthine guanine phosphoribosyl transferase (HGprt) leads to a characteristic neurobehavioral phenotype dominated by dystonia, cognitive deficits and incapacitating self-injurious behavior. It has been known for decades that L...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167210/ https://www.ncbi.nlm.nih.gov/pubmed/35660973 http://dx.doi.org/10.1007/s00018-022-04326-x |
_version_ | 1784720777454551040 |
---|---|
author | Witteveen, J. S. Loopstok, S. R. Ballesteros, L. Luque Boonstra, A. van Bakel, N. H. M. van Boekel, W. H. P. Martens, G. J. M. Visser, J. E. Kolk, S. M. |
author_facet | Witteveen, J. S. Loopstok, S. R. Ballesteros, L. Luque Boonstra, A. van Bakel, N. H. M. van Boekel, W. H. P. Martens, G. J. M. Visser, J. E. Kolk, S. M. |
author_sort | Witteveen, J. S. |
collection | PubMed |
description | In Lesch–Nyhan disease (LND), deficiency of the purine salvage enzyme hypoxanthine guanine phosphoribosyl transferase (HGprt) leads to a characteristic neurobehavioral phenotype dominated by dystonia, cognitive deficits and incapacitating self-injurious behavior. It has been known for decades that LND is associated with dysfunction of midbrain dopamine neurons, without overt structural brain abnormalities. Emerging post mortem and in vitro evidence supports the hypothesis that the dopaminergic dysfunction in LND is of developmental origin, but specific pathogenic mechanisms have not been revealed. In the current study, HGprt deficiency causes specific neurodevelopmental abnormalities in mice during embryogenesis, particularly affecting proliferation and migration of developing midbrain dopamine (mDA) neurons. In mutant embryos at E14.5, proliferation was increased, accompanied by a decrease in cell cycle exit and the distribution and orientation of dividing cells suggested a premature deviation from their migratory route. An abnormally structured radial glia-like scaffold supporting this mDA neuronal migration might lie at the basis of these abnormalities. Consequently, these abnormalities were associated with an increase in area occupied by TH(+) cells and an abnormal mDA subpopulation organization at E18.5. Finally, dopaminergic innervation was disorganized in prefrontal and decreased in HGprt deficient primary motor and somatosensory cortices. These data provide direct in vivo evidence for a neurodevelopmental nature of the brain disorder in LND. Future studies should not only focus the specific molecular mechanisms underlying the reported neurodevelopmental abnormalities, but also on optimal timing of therapeutic interventions to rescue the DA neuron defects, which may also be relevant for other neurodevelopmental disorders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04326-x. |
format | Online Article Text |
id | pubmed-9167210 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-91672102022-06-06 HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease Witteveen, J. S. Loopstok, S. R. Ballesteros, L. Luque Boonstra, A. van Bakel, N. H. M. van Boekel, W. H. P. Martens, G. J. M. Visser, J. E. Kolk, S. M. Cell Mol Life Sci Original Article In Lesch–Nyhan disease (LND), deficiency of the purine salvage enzyme hypoxanthine guanine phosphoribosyl transferase (HGprt) leads to a characteristic neurobehavioral phenotype dominated by dystonia, cognitive deficits and incapacitating self-injurious behavior. It has been known for decades that LND is associated with dysfunction of midbrain dopamine neurons, without overt structural brain abnormalities. Emerging post mortem and in vitro evidence supports the hypothesis that the dopaminergic dysfunction in LND is of developmental origin, but specific pathogenic mechanisms have not been revealed. In the current study, HGprt deficiency causes specific neurodevelopmental abnormalities in mice during embryogenesis, particularly affecting proliferation and migration of developing midbrain dopamine (mDA) neurons. In mutant embryos at E14.5, proliferation was increased, accompanied by a decrease in cell cycle exit and the distribution and orientation of dividing cells suggested a premature deviation from their migratory route. An abnormally structured radial glia-like scaffold supporting this mDA neuronal migration might lie at the basis of these abnormalities. Consequently, these abnormalities were associated with an increase in area occupied by TH(+) cells and an abnormal mDA subpopulation organization at E18.5. Finally, dopaminergic innervation was disorganized in prefrontal and decreased in HGprt deficient primary motor and somatosensory cortices. These data provide direct in vivo evidence for a neurodevelopmental nature of the brain disorder in LND. Future studies should not only focus the specific molecular mechanisms underlying the reported neurodevelopmental abnormalities, but also on optimal timing of therapeutic interventions to rescue the DA neuron defects, which may also be relevant for other neurodevelopmental disorders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04326-x. Springer International Publishing 2022-06-04 2022 /pmc/articles/PMC9167210/ /pubmed/35660973 http://dx.doi.org/10.1007/s00018-022-04326-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Witteveen, J. S. Loopstok, S. R. Ballesteros, L. Luque Boonstra, A. van Bakel, N. H. M. van Boekel, W. H. P. Martens, G. J. M. Visser, J. E. Kolk, S. M. HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease |
title | HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease |
title_full | HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease |
title_fullStr | HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease |
title_full_unstemmed | HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease |
title_short | HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease |
title_sort | hgprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of lesch–nyhan disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167210/ https://www.ncbi.nlm.nih.gov/pubmed/35660973 http://dx.doi.org/10.1007/s00018-022-04326-x |
work_keys_str_mv | AT witteveenjs hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease AT loopstoksr hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease AT ballesteroslluque hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease AT boonstraa hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease AT vanbakelnhm hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease AT vanboekelwhp hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease AT martensgjm hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease AT visserje hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease AT kolksm hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease |